705752 |
Brazil |
ControlLab Controle de Qualidade para Laboratórios Ltda
ControlLab Controle de Qualidade para Laboratórios Ltda
|
Clinical PT - TLR Coronavírus (SARS-CoV2): antigen
[EP Clínico - TLR Coronavírus (SARS-CoV2): antígeno]
Clinical PT - TLR Coronavírus (SARS-CoV2): antigen
[EP Clínico - TLR Coronavírus (SARS-CoV2): antígeno]
|
2020-09-10 |
|
PT name |
(Clinical PT - TLR Coronavírus (SARS-CoV2): antigen) |
Scheme name in national language |
(EP Clínico - TLR Coronavírus (SARS-CoV2): antígeno) |
Tested property |
(Coronavírus (SARS-CoV2)) |
|
705734 |
Brazil |
ControlLab Controle de Qualidade para Laboratórios Ltda
ControlLab Controle de Qualidade para Laboratórios Ltda
|
Clinical PT - Immunology Coronavírus (SARS-CoV2): Automation
[EP Clínico - Imunologia Coronavírus (SARS-CoV2): Automação ]
Clinical PT - Immunology Coronavírus (SARS-CoV2): Automation
[EP Clínico - Imunologia Coronavírus (SARS-CoV2): Automação ]
|
2020-09-10 |
|
PT name |
(Clinical PT - Immunology Coronavírus (SARS-CoV2): Automation) |
Scheme name in national language |
(EP Clínico - Imunologia Coronavírus (SARS-CoV2): Automação) |
|
705717 |
Brazil |
ControlLab Controle de Qualidade para Laboratórios Ltda
ControlLab Controle de Qualidade para Laboratórios Ltda
|
Clinical PT - Molecular Biology Coronavírus (SARS-CoV2)
[EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2)]
Clinical PT - Molecular Biology Coronavírus (SARS-CoV2)
[EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2)]
|
2023-01-31 |
|
PT name |
(Clinical PT - Molecular Biology Coronavírus (SARS-CoV2)) |
Scheme name in national language |
(EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2)) |
Tested property |
(Coronavírus (SARS-CoV2)) |
|
699949 |
United Kingdom |
UK NEQAS for Immunology, Immunochemistry & Allergy
UK NEQAS for Immunology, Immunochemistry & Allergy
|
UK NEQAS for SARS-CoV-2 / COVID-19 Antibodies
UK NEQAS for SARS-CoV-2 / COVID-19 Antibodies
|
2023-05-30 |
|
PT name |
(UK NEQAS for SARS-CoV-2 / COVID-19 Antibodies) |
Tested property |
(SARS-CoV-2 / COVID-19 Antibodies) |
|
690914 |
Argentina |
ILT - Interlaboratory Test S.A.
ILT - Interlaboratory Test S.A.
|
Face mask (relevant to SARS-CoV-2 virus / COVID-19 disease) - ILT-U-2091 / ILT-U-2097 / ILT-U-2100 / ILT-U-2112
Face mask (relevant to SARS-CoV-2 virus / COVID-19 disease) - ILT-U-2091 / ILT-U-2097 / ILT-U-2100 / ILT-U-2112
|
2020-09-16 |
|
PT name |
(Face mask (relevant to SARS-CoV-2 virus / COVID-19 disease) - ILT-U-2091 / ILT-U-2097 / ILT-U-2100 / ILT-U-2112) |
|
690909 |
Argentina |
ILT - Interlaboratory Test S.A.
ILT - Interlaboratory Test S.A.
|
ILT-U-2072 - Respiratory protective devices (relevant to SARS-CoV-2 virus / COVID-19 disease)
ILT-U-2072 - Respiratory protective devices (relevant to SARS-CoV-2 virus / COVID-19 disease)
|
2020-06-09 |
|
PT name |
(ILT-U-2072 - Respiratory protective devices (relevant to SARS-CoV-2 virus / COVID-19 disease)) |
Tested property |
(Requirements, testing, marking for COVID-19) |
|
437169 |
Germany |
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
|
Virus Genome Detection – Coronaviruses incl. SARS-CoV-2 (340)
[Virusgenom-Nachweis – Coronaviren inkl. SARS-CoV-2 (340)]
Virus Genome Detection – Coronaviruses incl. SARS-CoV-2 (340)
[Virusgenom-Nachweis – Coronaviren inkl. SARS-CoV-2 (340)]
|
2024-04-16 |
|
PT name |
(Virus Genome Detection – Coronaviruses incl. SARS-CoV-2 (340)) |
Scheme name in national language |
(Virusgenom-Nachweis – Coronaviren inkl. SARS-CoV-2 (340)) |
Tested property |
(Polymerase chain reaction (PCR) and other nucleic acid amplification techniques (NAT) for SARS-CoV) (Option for differentiaton between SARS-CoV-2, MERS-CoV and other human coronaviruses (samples which) (contain SARS-CoV-2 and MERS-CoV, repectively, are inactivated) |
|
302644 |
United Kingdom |
LGC AXIO Proficiency Testing
LGC AXIO Proficiency Testing
|
Environmental Hygiene Monitoring Scheme- HYGIENE
Environmental Hygiene Monitoring Scheme- HYGIENE
|
2021-09-06 |
|
Test item |
(Surface testing (swab rinsate) for SARS-CoV-2 molecular) |
Tested property |
(SARS-CoV-2) |
|
143893 |
United Kingdom |
LGC AXIO Proficiency Testing
LGC AXIO Proficiency Testing
|
Cosmetics and Toiletries Scheme (COSMETICS)
Cosmetics and Toiletries Scheme (COSMETICS)
|
2023-09-11 |
|
Tested property |
(Relevant to SARS-CoV-2 pandemic) |
|
138199 |
United States |
Collaborative Testing Services
Collaborative Testing Services
|
CTS Agriculture Laboratory Proficiency (ALP) Program: Water
CTS Agriculture Laboratory Proficiency (ALP) Program: Water
|
2019-05-23 |
|
Tested property |
(Sum Cations, SAR, ADJ-SAR) |
|
134427 |
United Kingdom |
LGC AXIO Proficiency Testing
LGC AXIO Proficiency Testing
|
Water Microbiology Scheme - (QWAS)
Water Microbiology Scheme - (QWAS)
|
2021-03-01 |
|
Tested property |
(SARS-CoV-2) (Detection of SARS-CoV-2) (Optional quantification of SARS-CoV-2 (Trial)) |
Testing method |
(2 x 1.5 ml vial (A & B) of non-infectious, SARS-CoV-2 virus (whole genome) 1 x >100ml sterile water diluent 1 x >20g sterile sludge matrix) |
|
1163345 |
Germany |
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
|
Virus Genome Detection – SARS-CoV-2 sequence analysis (417)
[Virusgenom-Nachweis - SARS-CoV-2 Sequenzanalyse (417)]
Virus Genome Detection – SARS-CoV-2 sequence analysis (417)
[Virusgenom-Nachweis - SARS-CoV-2 Sequenzanalyse (417)]
|
2024-04-16 |
|
PT name |
(Virus Genome Detection – SARS-CoV-2 sequence analysis (417)) |
Remarks |
(Please note:
Starting in 2024, only results of SARS-CoV-2 sequence analyses for SARS-CoV-2) |
Scheme name in national language |
(Virusgenom-Nachweis - SARS-CoV-2 Sequenzanalyse (417)) |
Tested property |
(Differentiation of SARS-CoV-2 variants with clinical relevance using whole genome sequencing) |
|
1163338 |
Germany |
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
|
Virus Genome Detection – SARS-CoV-2 (409)
[Virusgenom-Nachweis - SARS-CoV-2 (409)]
Virus Genome Detection – SARS-CoV-2 (409)
[Virusgenom-Nachweis - SARS-CoV-2 (409)]
|
2024-04-16 |
|
PT name |
(Virus Genome Detection – SARS-CoV-2 (409)) |
Scheme name in national language |
(Virusgenom-Nachweis - SARS-CoV-2 (409)) |
Tested property |
(The sample set contains defined samples with SARS-CoV-2 (full virus, inactivated) and, if necessary) (Polymerase chain reaction (PCR) and other nucleic acid amplification techniques (NAT) for SARS-CoV-2) |
|
1163321 |
Germany |
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
|
Virus Genome Detection – Respiratory Virus Panel 2 for Multiplex Tests (432)
[Virusgenom-Nachweis - Respiratorisches Virus-Panel 2 für Multiplex Teste (432)]
Virus Genome Detection – Respiratory Virus Panel 2 for Multiplex Tests (432)
[Virusgenom-Nachweis - Respiratorisches Virus-Panel 2 für Multiplex Teste (432)]
|
2024-04-16 |
|
Tested property |
(influenza A and B viruses incl. avian influenza A viruses, respiratory syncytial viruses (groups A and B) and SARS-CoV-2 (inactivated)) |
|
1163304 |
Germany |
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
|
Virus Genome Detection – Respiratory Virus Panel 1 for Multiplex Tests (431)
[Virusgenom-Nachweis - Respiratorisches Virus-Panel 1 für Multiplex Teste (431)]
Virus Genome Detection – Respiratory Virus Panel 1 for Multiplex Tests (431)
[Virusgenom-Nachweis - Respiratorisches Virus-Panel 1 für Multiplex Teste (431)]
|
2024-04-16 |
|
Tested property |
(incl. avian influenza A viruses, parecho, parainfluenza, respiratory syncytial viruses (groups A and B) and SARS-CoV-2 (inactivated), respectively) |
|
1160040 |
Germany |
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
|
Virus Antigen Detection – SARS-CoV-2 (Ag) (410)
[Virusantigen-Nachweis - SARS-CoV-2 (Ag) (410)]
Virus Antigen Detection – SARS-CoV-2 (Ag) (410)
[Virusantigen-Nachweis - SARS-CoV-2 (Ag) (410)]
|
2024-04-16 |
|
PT name |
(Virus Antigen Detection – SARS-CoV-2 (Ag) (410)) |
Remarks |
(samples with antigen from SARS-CoV-2 (inactivated) and, if necessary, samples with antigen from human) (immunoassays for the detection of SARS-CoV-2 antigen.
The interdisciplinary, non-profit) |
Scheme name in national language |
(Virusantigen-Nachweis - SARS-CoV-2 (Ag) (410)) |
Tested property |
(SARS-CoV-2 antigen) |
|
1138638 |
Canada |
CMPT - Canadian Microbiology Proficiency Testing
CMPT - Canadian Microbiology Proficiency Testing
|
COVID-19
COVID-19
|
2024-01-23 |
|
PT name |
(COVID-19) |
Tested property |
(SARS CoV-2) |
|
1129430 |
Spain |
ielab
ielab
|
SARS-CoV-2
[SARS-CoV-2]
SARS-CoV-2
[SARS-CoV-2]
|
2023-11-29 |
|
PT name |
(SARS-CoV-2) |
Scheme name in national language |
(SARS-CoV-2) |
Tested property |
(SARS-CoV-2) |
|
1083473 |
Brazil |
METROCERT
METROCERT
|
P-021 - Proficiency testing program for Specific Absorption Rate (SAR) testing on a cellular mobile phone
[P-021 - Programa de ensaio de proficiência para ensaio de Taxa de Absorção Específica (SAR) em telefone móvel celular]
P-021 - Proficiency testing program for Specific Absorption Rate (SAR) testing on a cellular mobile phone
[P-021 - Programa de ensaio de proficiência para ensaio de Taxa de Absorção Específica (SAR) em telefone móvel celular]
|
2023-10-19 |
|
PT name |
(P-021 - Proficiency testing program for Specific Absorption Rate (SAR) testing on a cellular mobile phone) |
Scheme name in national language |
(P-021 - Programa de ensaio de proficiência para ensaio de Taxa de Absorção Específica (SAR) em telefone móvel celular) |
Tested property |
(Specific Absorption Rate (SAR)) |
|
1051761 |
Brazil |
ControlLab Controle de Qualidade para Laboratórios Ltda
ControlLab Controle de Qualidade para Laboratórios Ltda
|
Clinical PT - Sequencing: Coronavirus (SARS-CoV2)
[EP Clínico - Sequenciamento: Sequenciamento: Coronavírus (SARS-Cov-2)]
Clinical PT - Sequencing: Coronavirus (SARS-CoV2)
[EP Clínico - Sequenciamento: Sequenciamento: Coronavírus (SARS-Cov-2)]
|
2023-05-29 |
|
PT name |
(Clinical PT - Sequencing: Coronavirus (SARS-CoV2)) |
Scheme name in national language |
(EP Clínico - Sequenciamento: Sequenciamento: Coronavírus (SARS-Cov-2)) |
|